Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.

MLA

Caserta, Mary T., et al. “Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.” Pediatrics, vol. 152, no. 1, July 2023. EBSCOhost, https://doi.org/10.1542/peds.2023-061803.

APA

Caserta, M. T., O’Leary, S. T., Munoz, F. M., & Ralston, S. L. (2023). Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics, 152(1). https://doi.org/10.1542/peds.2023-061803

Chicago

Caserta, Mary T, Sean T O’Leary, Flor M Munoz, and Shawn L Ralston. 2023. “Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.” Pediatrics 152 (1). doi:10.1542/peds.2023-061803.